Edward J. Dulac III, Chief Financial Officer at FATE THERAPEUTICS INC (FATE), sold 9,838 shares at $29.75 ($293K) on 2022-08-18, disclosed to the SEC on 2022-08-19.
Open-market sale of $293k FATE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.75 | 4,703 | $140K | 47.8% |
| 2 | $29.75 | 4,703 | $140K | 47.8% |
| 3 | $30.41 | 432 | $13K | 4.5% |
| Total | $29.78 avg | 9,838 | $293K | 100% |
| Filing → |
| NTLA | SELL | 2026-01-07 | $59K | — | Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |